Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome

Pediatric Nephrology

Volumn 20, Issue 1, 2005, Pages 96-98

  Kawasaki, Yukihiko ^a   Suzuki, Junzo ^a   Takahashi, Ai ^a   Isome, Masato ^a   Nozawa, Ruriko ^a   Suzuki, Hitoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Mizoribine oral pulse therapy; Prednisolone; Steroid dependent nephrotic syndrome

Indexed keywords

ALLOPURINOL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; STEROID;

ARTICLE; CASE REPORT; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; RELAPSE; REMISSION; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; UREMIA;

ADMINISTRATION, ORAL; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEPHROTIC SYNDROME; PULSE THERAPY, DRUG; RIBONUCLEOSIDES; TREATMENT OUTCOME;

EID: 11244264426     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1647-1     Document Type: Article

References (9)

1. Hughes SE, Gruber SA (1996) New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 36:1081-1092 1:CAS:528:DyaK2sXhtVWjsrg%3D 9013363
2. Ishikawa H (1999) Mizoribine and mycophenolate mofetil. Curr Med Chem 6:575-597 1:CAS:528:DyaK1MXks1Onsrc%3D 10390602
3. Hamasaki T, Mori M, Kinoshita Y, Saeki T, Sakano T (1997) Mizoribine in steroid-dependent nephrotic syndrome of childhood. Pediatr Nephrol 11:625-627 10.1007/s004670050351 1:STN:280:ByiH28vlsl0%3D 9323293
4. Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S, for the Pediatric Mizoribine Study Group in Japan (2000) A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int. 58:317-324
5. Aihara Y, Miyamae T, Ito S, Kobayashi S, Imagawa T, Mori M, Ibe M, Mitsuda T, Yokota S (2002) Mizoribine as an effective combined maintenance therapy with prednisolone in childhood-onset systemic lupus erythematosus. Pediatr Int 44:199-204 10.1046/j.1328-8067.2001.01534.x 1:CAS:528:DC%2BD38XjtlCisb0%3D 11896887
6. Kawasaki Y, Suzuki J, Sakai N, Etoh S, Murai H, Nozawa R, Suzuki H (2004) Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy. Am J Nephrol 24:147-153 10.1159/000076243 1:CAS:528:DC%2BD2cXht1ahtL0%3D 14726626
7. Tanaka H, Suzuki K, Nakahata T, Sato T, Ito E (2003) Mizoribine oral pulse therapy for a patients with severe lupus nephritis. Pediatr Int 45:488-490 12911493
8. Sonda K, Takahashi K, Tanaka K, Funchinoue S, Hayasaka Y, Kawaguchi H, Teraoka S, Toma H, Ota K (1996) Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc 28:3643-3648 1:CAS:528:DyaK2sXisFKjsg%3D%3D 8962403
9. Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H (2000) Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 274:87-92 10.1006/bbrc.2000.3104 1:CAS:528:DC%2BD3cXkvFarsbc%3D 10903900